Methods for the treatment of nasal hypersecretion

Patent 4385048 Issued on May 24, 1983. Estimated Expiration Date:

November 14, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

3312709

3472861

Inventors

Assignee

Boehringer Ingelheim GmbH

Application

No. 06/208411 filed on 11/14/1980

US Classes:

424/45, Organic pressurized fluid514/304Tropanes (including nor or dehydro form)

Examiners

Primary: Schenkman, Leonard

Attorney, Agent or Firm

Hammond & Littell, Weissenberger & Muserlian

International Classes

A61K 31/135 (20060101)
A61K 31/46 (20060101)

Foreign Application Priority Data

1979-02-02 DE

Abstract

Compositions for the treatment of nasal hypersecretion comprising (8r)-8-isopropyl-3଱-[(&#b1;)-tropoyl-oxy]-1଱H, 5଱H-tropanium bromide in a pharmaceutical formulation suitable for topical application to the nasal cavity; and methods of use.

Other References

Goodman & Gilman, "The Pharmacological Basis of Therapeutics", 6th Ed., (1980), pp. 134-135
Chemical Abstracts, (Deckers), 84:173577f, (1976)
Goodman & Gilman-"The Pharmacological Basis of Therapeutics", 3rd Ed., 1965, pp. 521-527, & 540
Chemical Abstracts, 84:44483y, (1976)